PL373799A1 - Flashmelt oral dosage formulation - Google Patents

Flashmelt oral dosage formulation

Info

Publication number
PL373799A1
PL373799A1 PL01373799A PL37379901A PL373799A1 PL 373799 A1 PL373799 A1 PL 373799A1 PL 01373799 A PL01373799 A PL 01373799A PL 37379901 A PL37379901 A PL 37379901A PL 373799 A1 PL373799 A1 PL 373799A1
Authority
PL
Poland
Prior art keywords
oral dosage
dosage formulation
flashmelt
flashmelt oral
formulation
Prior art date
Application number
PL01373799A
Other languages
Polish (pl)
Inventor
Sanjeev Kothari
Divyakant Desai
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Priority to PL01373799A priority Critical patent/PL373799A1/en
Publication of PL373799A1 publication Critical patent/PL373799A1/en

Links

PL01373799A 2001-10-09 2001-10-09 Flashmelt oral dosage formulation PL373799A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL01373799A PL373799A1 (en) 2001-10-09 2001-10-09 Flashmelt oral dosage formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL01373799A PL373799A1 (en) 2001-10-09 2001-10-09 Flashmelt oral dosage formulation

Publications (1)

Publication Number Publication Date
PL373799A1 true PL373799A1 (en) 2005-09-19

Family

ID=36645537

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01373799A PL373799A1 (en) 2001-10-09 2001-10-09 Flashmelt oral dosage formulation

Country Status (1)

Country Link
PL (1) PL373799A1 (en)

Similar Documents

Publication Publication Date Title
EG23943A (en) Flash-melt oral dosage formulation
IL156716A0 (en) Pharmaceutical formulation
PL367180A1 (en) Stabilized oral pharmaceutical composition
GB0319041D0 (en) Pharmaceutical Formulations
GB0117618D0 (en) Pharmaceutical dosage form
PL364621A1 (en) Nicotine-containing oral dosage form
EP1407785A4 (en) Medicinal compositions
HK1065944A1 (en) Medicinal compositions
GB0118689D0 (en) Pharmaceutical formulation
HUP0400850A3 (en) Oral pharmaceutical compositions
GB0117619D0 (en) Pharmaceutical dosage form
HUP0500638A2 (en) Flashmelt oral dosage formulation
EP1398040A4 (en) Medicinal composition
GB0120701D0 (en) Pharmaceutical formulations
GB0103638D0 (en) Pharmaceutical formulations
GB0121715D0 (en) Pharmaceutical formulations
GB2380129B (en) Pharmaceutical formulations
GB0105560D0 (en) Pharmaceutical formulations
HUP0401599A3 (en) Extended release oral dosage form
GB0114746D0 (en) Medicinal composition
GB0124455D0 (en) Pharmaceutical formulations
PL373799A1 (en) Flashmelt oral dosage formulation
GB0104749D0 (en) Pharmaceutical formulation
EP1413314A4 (en) Medicinal compositions
GB0124712D0 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)